News

$260,000 of DEXCOM INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
Issues related to global supply chains"

You can find more data on corporate lobbying on Quiver Quantitative.

DXCM Congressional Stock Trading

Members of Congress have traded $DXCM stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $DXCM stock by members of Congress over the last 6 months:

• REPRESENTATIVE KEVIN HERN sold up to $100,000 on 12/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

DXCM Insider Trading Activity

DXCM insiders have traded $DXCM stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $DXCM stock by insiders over the last 6 months:

• SADIE STERN (EVP, Chief HR Officer) has made 0 purchases and 3 sales selling 5,109 shares for an estimated $380,325.
• JEREME M SYLVAIN (EVP, Chief Financal Officer) has made 0 purchases and 3 sales selling 4,990 shares for an estimated $373,062.
• BRIDGETTE P HELLER has made 0 purchases and 2 sales selling 2,000 shares for an estimated $146,870.
• JACOB STEVEN LEACH (EVP, Chief Operating Officer) has made 0 purchases and 2 sales selling 1,490 shares for an estimated $108,777.
• MICHAEL JON BROWN (EVP, Chief Legal Officer) has made 0 purchases and 2 sales selling 1,338 shares for an estimated $93,366.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DXCM Hedge Fund Activity

We have seen 426 institutional investors add shares of DXCM stock to their portfolio, and 534 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JENNISON ASSOCIATES LLC added 6,544,102 shares (+1683.2%) to their portfolio in Q3 2024, for an estimated $438,716,598
• FMR LLC removed 6,400,806 shares (-65.4%) from their portfolio in Q3 2024, for an estimated $429,110,034
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 6,238,605 shares (-93.4%) from their portfolio in Q3 2024, for an estimated $418,236,079
• CAPITAL RESEARCH GLOBAL INVESTORS added 6,002,727 shares (+50.3%) to their portfolio in Q3 2024, for an estimated $402,422,818
• ARTISAN PARTNERS LIMITED PARTNERSHIP removed 3,975,406 shares (-70.6%) from their portfolio in Q3 2024, for an estimated $266,511,218
• D. E. SHAW & CO., INC. added 2,393,783 shares (+6697.8%) to their portfolio in Q3 2024, for an estimated $160,479,212
• FRANKLIN RESOURCES INC removed 1,841,383 shares (-45.8%) from their portfolio in Q3 2024, for an estimated $123,446,316

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.